Protein L - 20nm Gold Conjugate
Cytodiagnostics
SKU:AC-20-19-05
Couldn't load pickup availability

Protein L - 20nm Gold Conjugate for gold nanoparticle labelling
Protein L - 20nm Gold Conjugate supports method development where antibody light chains through Protein L binding must be detected in Lateral Flow Assay, Immunoblotting and Electron Microscopy. It helps researchers evaluate target fit, assay readout and control strategy before selecting a related label or antibody format.
Workflow value
The colloidal gold label provides a permanent, electron-dense and optically visible signal for method development and routine detection workflows. This compact gold format gives a balance of accessibility and signal, making it useful across immunoblotting and microscopy method development.
Use-case guidance
- Supports Lateral Flow Assay, Immunoblotting and Electron Microscopy workflows where Protein L signal needs to be interpreted with appropriate controls.
- Useful when light-chain binding is preferred, especially for workflows where Fc-dependent recognition is less suitable.
- Include matched negative controls and optimize blocking to separate true target-associated signal from nonspecific particle binding.
Reference AC-20-19-05 in protocols, purchasing notes and internal reagent libraries when matching this product to your chosen assay. For protocol transfer, record the catalog reference together with the selected application and control strategy.
- Research Area:
- Bioconjugation & Labeling • Assay Development • Nanotechnology & Biosensors
- Application:
- Lateral Flow Assay • Immunoblotting • Electron Microscopy
- Host:
- P. Magnus
- Formulation:
- 1XPBS (pH 7.4), 20% glycerol (v/v), 1% BSA
- Adsorption Max:
- 524nm
- Core Size:
- 20nm
- Shape:
- Spherical
- Material:
- Gold
- Storage Temperature:
- 4°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.